Capsular polysaccharide K5 OR 42615-44-1 [rn] - Search Results

Year	Number of Results
1981	1
1986	1
1991	1
1993	3
1994	1
1995	1
1996	4
1998	2
1999	3
2000	3
2001	1
2002	2
2003	4
2004	4
2005	4
2006	2
2007	3
2008	6
2009	6
2010	3
2011	3
2012	4
2013	1
2014	2
2015	6
2016	1
2017	3
2018	1
2019	1
2020	1
2021	1
2024	0

1

The non-anticoagulant heparin-like K5 polysaccharide derivative K5-N,OSepi attenuates myocardial ischaemia/reperfusion injury.

Collino M, Pini A, Mastroianni R, Benetti E, Lanzi C, Bani D, Manoni M, Fantozzi R, Masini E. Collino M, et al. J Cell Mol Med. 2012 Sep;16(9):2196-207. doi: 10.1111/j.1582-4934.2012.01530.x. J Cell Mol Med. 2012. PMID: 22248092 Free PMC article.

2

Biosynthesis of the Escherichia coli K5 capsular polysaccharide.

Griffiths G, Barrett B, Cook N, Roberts IS. Griffiths G, et al. Biochem Soc Trans. 1999 Aug;27(4):507-12. doi: 10.1042/bst0270507. Biochem Soc Trans. 1999. PMID: 10917630 Review. No abstract available.

3

A Revised Structure for the Glycolipid Terminus of Escherichia coli K5 Heparosan Capsular Polysaccharide.

Yan L, Fu L, Xia K, Chen S, Zhang F, Dordick JS, Linhardt RJ. Yan L, et al. Biomolecules. 2020 Nov 6;10(11):1516. doi: 10.3390/biom10111516. Biomolecules. 2020. PMID: 33171953 Free PMC article.

4

Expression of the capsular K5 polysaccharide of Escherichia coli: biochemical and electron microscopic analyses of mutants with defects in region 1 of the K5 gene cluster.

Bronner D, Sieberth V, Pazzani C, Roberts IS, Boulnois GJ, Jann B, Jann K. Bronner D, et al. J Bacteriol. 1993 Sep;175(18):5984-92. doi: 10.1128/jb.175.18.5984-5992.1993. J Bacteriol. 1993. PMID: 8397188 Free PMC article.

5

Sulfated K5 Escherichia coli polysaccharide derivatives: A novel class of candidate antiviral microbicides.

Rusnati M, Vicenzi E, Donalisio M, Oreste P, Landolfo S, Lembo D. Rusnati M, et al. Pharmacol Ther. 2009 Sep;123(3):310-22. doi: 10.1016/j.pharmthera.2009.05.001. Epub 2009 May 14. Pharmacol Ther. 2009. PMID: 19447134 Review.

6

Stimulation of RAW264.7 macrophages by sulfated Escherichia coli K5 capsular polysaccharide in vitro.

Teng L, Fu H, Wang M, Deng C, Chen J. Teng L, et al. Mol Med Rep. 2015 Oct;12(4):5545-53. doi: 10.3892/mmr.2015.4082. Epub 2015 Jul 16. Mol Med Rep. 2015. PMID: 26239044

7

Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV-1 Tat protein antagonists.

Urbinati C, Bugatti A, Oreste P, Zoppetti G, Waltenberger J, Mitola S, Ribatti D, Presta M, Rusnati M. Urbinati C, et al. FEBS Lett. 2004 Jun 18;568(1-3):171-7. doi: 10.1016/j.febslet.2004.05.033. FEBS Lett. 2004. PMID: 15196942 Free article.

8

Biotechnological engineering of heparin/heparan sulphate: a novel area of multi-target drug discovery.

Rusnati M, Oreste P, Zoppetti G, Presta M. Rusnati M, et al. Curr Pharm Des. 2005;11(19):2489-99. doi: 10.2174/1381612054367553. Curr Pharm Des. 2005. PMID: 16026302 Review.

9

Analysis of E. coli K5 capsular polysaccharide heparosan.

Ly M, Wang Z, Laremore TN, Zhang F, Zhong W, Pu D, Zagorevski DV, Dordick JS, Linhardt RJ. Ly M, et al. Anal Bioanal Chem. 2011 Jan;399(2):737-45. doi: 10.1007/s00216-010-3679-7. Epub 2010 Apr 21. Anal Bioanal Chem. 2011. PMID: 20407891 Free PMC article.

10

Broad spectrum inhibition of HIV-1 infection by sulfated K5 Escherichia coli polysaccharide derivatives.

Vicenzi E, Gatti A, Ghezzi S, Oreste P, Zoppetti G, Poli G. Vicenzi E, et al. AIDS. 2003 Jan 24;17(2):177-81. doi: 10.1097/00002030-200301240-00006. AIDS. 2003. PMID: 12545076

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

69 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Results by year